MedTrace Logo

A Preliminary Study on Digital Learning Aids for Special Children With TRIZ and 3D Printing Technology

NCT05935462 · Status: AVAILABLE · Type: EXPANDED_ACCESS

Last updated 2024-12-16

No results posted yet for this study

Summary

During the transition phase from early intervention to primary education (4.5 years to 8.11 years), children with special needs may encounter difficulties in using digital learning media. The investigators intend to apply the TRIZ analysis method to enhance children's participation in learning. Additionally, the investigators plan to design a preliminary model of learning aids and conduct a trial.

Conditions

  • Digital Learning Aids for Special Children

Interventions

COMBINATION_PRODUCT

Digital Learning Aids

Recruitment is currently underway for special children undergoing outpatient early intervention. Among the recruited participants, five children between the ages of 6 and 9, who are receiving early intervention, were screened. After obtaining their consent to participate in this study, their basic information was recorded, including gender, age, education, diagnosis, Movement Assessment Battery for Children (MABC-2), Visual-Motor Integration (VMI) test, and Children's ABILHAND questionnaire for manual ability. Once the collection of basic information is completed, a trial of digital aids will be conducted, and a trial feedback questionnaire will be administered. The trial period will consist of a 20-minute session and 2-3 sessions (per week) of home (or therapy room) use.

Sponsors & Collaborators

  • Taipei Medical University

    collaborator OTHER

  • Taipei Medical University Shuang Ho Hospital

    lead OTHER

Eligibility

Min Age
6 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05935462 on ClinicalTrials.gov